Manhattan Research Releases Digital DTC Relevance Rankings, Revealing Which Condition Groups Are Most Likely to Adopt eHealth
-Acne, Restless Leg Syndrome, and Cancer Patients are Among the Top Condition Groups Shaping the Future of Digital DTC Marketing
New York, April 8, 2009 - More than 60% of U.S. adults turn to the Internet as a decision support tool in healthcare and disease management, and certain condition groups are more likely to use online health resources than others, according to pharmaceutical and healthcare market research company Manhattan Research. Acne, restless leg syndrome, and cancer patients are among the top ten therapeutic categories adopting eHealth activities, which can range from reading a health-related blog to joining an online patient community. The increasing use of consumer reliance on the Internet for health and pharmaceutical information is transforming digital direct-to-consumer (DTC) marketing from a "nice to have" tactic to an essential communication channel for pharma companies reaching consumer audiences.
Manhattan Research releases its Digital DTC Relevance Rankings, revealing which condition groups are most likely to use the Internet for health information out of a pool of over 100 therapeutic categories. The findings come from Cybercitizen Health(tm) v8.0, the company's consumer market research and advisory service. The Digital DTC Relevance chart shows that for some brands, such as those targeting acne, adult ADHD, and fibromyalgia patients, it's especially critical to take note of digital opportunities in shaping future DTC marketing strategies.
Digital DTC Relevance Rankings Top Condition Groups Online for Health Ranked by number of U.S. adults Position Condition 1. Acne 2. Adult ADHD (Attention Deficit Hyperactivity Disorder) 3. Fibromyalgia 4. Migraine 5. Allergies 6. Irritable Bowel Syndrome 7. Anxiety Disorder/Social Phobia 8. Asthma 9. Restless Leg Syndrome 10. Cancer
Among U.S. adults (18+) Source: Cybercitizen Health(tm) v8.0 (2008)
"This is the year in which pharmaceutical companies must stop merely 'talking at' consumers and begin communicating with them. The old way of DTC marketing isn't going to cut it as the consumer media landscape evolves," said Meredith Abreu Ressi, Vice President of Research at Manhattan Research. "Though we've shared just a few of the top condition groups online for health, the reality is that all pharmaceutical marketers are finding that their target audiences are shifting from traditional offline sources to the Internet for their everyday needs, including health management."
Manhattan Research at the DTC National Conference
Manhattan Research Vice President of Research Meredith Abreu Ressi will be presenting "How New Media Changes Pharmaceutical DTC Advertising" with Jeff Hitchcock, President and Founder of Children with Diabetes, a Johnson and Johnson Company, at the DTC National Conference on Thursday, April 16, 2009 in Washington D.C.
For more information about the DTC National Conference, please visit: http://www.dtcperspectives.com/website/Conferences/DTC-National/DTC-National-Main.html
To connect with Manhattan Research at DTC National, please contact Claire Anastasia at email@example.com or 212-255-7024.
Request a Complimentary Overview of Digital Trends for Your Therapeutic Audience
Manhattan Research offers complimentary overviews of how over 100 consumer therapeutic groups use the Internet and other technology for healthcare. This one-page snapshot is a preview of Manhattan Research's Therapeutic Segmentation Modules, which are comprehensive analyses of specific patient markets based on the Cybercitizen Health(tm) and ePharma Consumer® studies. To request an overview of digital trends for your therapeutic audience, please visit http://www.manhattanresearch.com/products/Therapeutic_Segmentations/therapeutic-segmentation-overview-request.aspx
For a list of available consumer therapeutic segmentation modules and topics, please visit http://www.manhattanresearch.com/products/Therapeutic_Segmentations
For a list of available physician specialist segmentation modules and topics, please visit http://www.manhattanresearch.com/products/Specialist_Segmentations
For additional segmentation module product and purchasing information, please contact firstname.lastname@example.org or call 1.888.680.0800, ext 2.
About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm. We conduct annual research studies covering eHealth trends among physicians and consumers, including Taking the Pulse®, Taking the Pulse® Europe, Taking the Pulse® Asia, Cybercitizen Health(tm), Cybercitizen Health(tm) Europe, ePharma Consumer®, and ePharma Physician®. Broad consumer and physician research is complemented by targeted analysis among more than 100 consumer therapeutic segments and 25 physician specialist segments. For information, please contact email@example.com, call 1.888.680.0800, or visit http://www.manhattanresearch.com.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.decisionresourcesinc.com.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact:
Manhattan Research Maureen Malloy 212-255-7799 firstname.lastname@example.org
Maureen Malloy | Manager, Marketing & Corporate Communications | manhattanRESEARCH 27 W 24th Street | New York, NY 10010 | USA Office: +1 212 255 7799 | Fax: +1 212 937 2080 Email: email@example.com
Posted: April 2009